Quick Answer
CEL SCI CORP reported Net Income of -$25.41 million for fiscal year 2025.
CEL SCI CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | -$25.41M +5.6% |
-$26.92M +16.8% |
-$32.37M +11.8% |
-$36.70M -0.9% |
-$36.36M -20.2% |
-$30.26M -36.7% |
| Diluted EPS | -$6.27 +59.0% |
-$15.31 -1997.3% |
-$0.73 +16.1% |
-$0.87 +3.3% |
-$0.90 | — |
| Total Assets | $28.16M +4.3% |
$26.99M -11.6% |
$30.53M -39.6% |
$50.52M -33.4% |
$75.87M +87.2% |
$40.54M +46.7% |
| Cash and Equivalents | — | — | — | $22.67M -37.1% |
$36.06M +132.5% |
$15.51M +83.7% |
| Stockholders Equity | $15.96M +24.0% |
$12.87M -2.6% |
$13.21M -58.9% |
$32.16M -43.1% |
$56.53M +186.6% |
$19.73M +284.3% |
| R&D Expense | $15.89M -12.5% |
$18.16M -19.2% |
$22.47M -11.4% |
$25.36M +9.7% |
$23.11M +29.5% |
$17.84M +40.9% |
| Operating Income | -$24.81M +5.9% |
-$26.35M +16.3% |
-$31.48M +12.7% |
-$36.06M +0.4% |
-$36.19M -24.9% |
-$28.99M -43.5% |
| Shares Outstanding | 8.02M +276.9% |
2.13M -95.5% |
47.42M +9.1% |
43.45M +0.6% |
43.21M +11.6% |
38.73M +9.9% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | June 30, 2011 | $77.4K | +150.5% | +150.5% |
| Net Income | December 31, 2025 | -$5.47M | +22.7% | +3.4% |
| Diluted EPS | December 31, 2025 | -$0.68 | +79.1% | +50.0% |
| Total Assets | December 31, 2025 | $22.89M | -10.9% | -18.7% |
| Cash and Equivalents | June 30, 2023 | $5.14M | -81.7% | -48.9% |
| Stockholders Equity | December 31, 2025 | $11.14M | -1.5% | -30.2% |
| R&D Expense | December 31, 2025 | $3.68M | -17.0% | -1.7% |
| Operating Income | December 31, 2025 | -$5.37M | +22.1% | +2.2% |
| Shares Outstanding | December 31, 2025 | 8.42M | -88.6% | +5.0% |
- CEL SCI CORP reported Net Income of -$25.41 million for fiscal year 2025.
- CEL SCI CORP showed an increase of +5.6% in Net Income compared to the prior fiscal year.
- CEL SCI CORP reported Diluted EPS of $6.27 per share (loss) for fiscal year 2025.
- CEL SCI CORP showed an increase of +59.0% in Diluted EPS compared to the prior fiscal year.
- CEL SCI CORP reported Total Assets of $28.16 million for fiscal year 2025.
- CEL SCI CORP showed an increase of +4.3% in Total Assets compared to the prior fiscal year.
- CEL SCI CORP reported Cash and Equivalents of $22.67 million for fiscal year 2022.
- CEL SCI CORP showed a decrease of -37.1% in Cash and Equivalents compared to the prior fiscal year.
- CEL SCI CORP reported Stockholders Equity of $15.96 million for fiscal year 2025.
- CEL SCI CORP showed an increase of +24.0% in Stockholders Equity compared to the prior fiscal year.
- CEL SCI CORP reported R&D Expense of $15.89 million for fiscal year 2025.
- CEL SCI CORP showed a decrease of -12.5% in R&D Expense compared to the prior fiscal year.
- CEL SCI CORP reported Operating Income of -$24.81 million for fiscal year 2025.
- CEL SCI CORP showed an increase of +5.9% in Operating Income compared to the prior fiscal year.
- CEL SCI CORP reported Shares Outstanding of 8.02 million shares for fiscal year 2025.
- CEL SCI CORP showed an increase of +276.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: